Rakovina Therapeutics Inc - ESG Rating & Company Profile powered by AI
If you are employed by Rakovina Therapeutics Inc and you would like to licence your Sustainability rating, please contact us. The ESG rating covers 17 UN SDGs including: 'Zero Hunger', 'Sustainable Cities & Communities' and 'Life below Water'. This page contains a questions and answers table about Rakovina Therapeutics Inc.
Rakovina Therapeutics Inc in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 4.0, social score of 5.3 and governance score of 8.0.
5.8
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Analytik Jena AG | 8.0 | High |
1 | Amniotics AB (publ) | 8.0 | High |
43 | Rhythm Biosciences Ltd | 6.2 | High |
45 | Captor Therapeutics SA | 6.0 | High |
46 | Rakovina Therapeutics Inc | 5.8 | High |
46 | Incanthera PLC | 5.8 | High |
46 | Fluicell AB | 5.8 | High |
... | ... | ... | |
182 | Wesana Health Holdings Inc | 0.0 | Low |
182 | rEVO Biologics Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Rakovina Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Rakovina Therapeutics Inc disclose current and historical energy intensity?
Does Rakovina Therapeutics Inc report the average age of the workforce?
Does Rakovina Therapeutics Inc reference operational or capital allocation in relation to climate change?
Does Rakovina Therapeutics Inc disclose its ethnicity pay gap?
Does Rakovina Therapeutics Inc disclose cybersecurity risks?
Does Rakovina Therapeutics Inc offer flexible work?
Does Rakovina Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Rakovina Therapeutics Inc disclose the number of employees in R&D functions?
Does Rakovina Therapeutics Inc conduct supply chain audits?
Does Rakovina Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Rakovina Therapeutics Inc conduct 360 degree staff reviews?
Does Rakovina Therapeutics Inc disclose the individual responsible for D&I?
Does Rakovina Therapeutics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Rakovina Therapeutics Inc disclose current and / or historical scope 2 emissions?
Does Rakovina Therapeutics Inc disclose water use targets?
Does Rakovina Therapeutics Inc have careers partnerships with academic institutions?
Did Rakovina Therapeutics Inc have a product recall in the last two years?
Does Rakovina Therapeutics Inc disclose incidents of discrimination?
Does Rakovina Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Has Rakovina Therapeutics Inc issued a profit warning in the past 24 months?
Does Rakovina Therapeutics Inc disclose parental leave metrics?
Does Rakovina Therapeutics Inc disclose climate scenario or pathway analysis?
Does Rakovina Therapeutics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Rakovina Therapeutics Inc disclose the pay ratio of women to men?
Does Rakovina Therapeutics Inc support suppliers with sustainability related research and development?
Does Rakovina Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Rakovina Therapeutics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Rakovina Therapeutics Inc involved in embryonic stem cell research?
Does Rakovina Therapeutics Inc disclose GHG and Air Emissions intensity?
Does Rakovina Therapeutics Inc disclose its waste policy?
Does Rakovina Therapeutics Inc report according to TCFD requirements?
Does Rakovina Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Rakovina Therapeutics Inc disclose energy use targets?
Does Rakovina Therapeutics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Rakovina Therapeutics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Rakovina Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Rakovina Therapeutics Inc., a biopharmaceutical company, focuses on development of cancer treatments based on novel DNA-damage response technologies. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. The company's lead pipeline products include kt-2000 Next Generation PARP-inhibitors; kt-3000 Dual Action DDR-inhibitors; and kt-4000 DNA Damaging DDR-inhibitors. Rakovina Therapeutics was founded in 2020 and is headquartered in Vancouver, Canada.